Presentation NY Valves 2025 Death on Waiting List for Transcatheter Aortic Valve Implantation: Current Incidence, Clinical Characteristics and Predictive Factors Presenter: Hugo Poinsignon June 25, 2025
Presentation NY Valves 2025 Correction of Doppler Gradients for LVOT Flow and Pressure Recovery Following Balloon-Expandable TAVR Presenter: Muhammad Suleman June 25, 2025
Presentation NY Valves 2025 Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials Presenter: Yasser M. Sammour June 25, 2025
Presentation NY Valves 2025 First in Human Study of the Microtech Novel Implantable Pressor Sensor in LVAD Patients Presenter: Nir Uriel June 25, 2025
Presentation NY Valves 2025 Keynote: Treatment Advances in Obstructive HCM with Drugs, Catheters and Surgery: Putting It All Together in 2025 Presenter: Martin Maron June 25, 2025
Presentation NY Valves 2025 Right Heart Remodeling Following TTVR With the VDyne System: Results From the VISTA EFS Program Presenter: Nadira Hamid June 25, 2025
Presentation NY Valves 2025 Mimicking Surgical Myotomy: Evolution of A Transcatheter Approach to Relieve Outflow Obstruction (SESAME) Presenter: Adam B. Greenbaum June 25, 2025
Presentation NY Valves 2025 30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial Presenter: Thomas Elie Modine June 25, 2025
Presentation NY Valves 2025 Progress in Surgery: Emergence of the Transapical Beating Heart Myectomy Presenter: Juan B. Grau June 25, 2025
Presentation NY Valves 2025 Early Feasibility Experience of Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace Implant (EXPLORE MR) Presenter: Fabio Sandoli de Brito June 25, 2025
Presentation NY Valves 2025 Impact of Myosin Inhibitors on Cardiac Remodeling in HCM: Different from Septal Reduction Therapies? Presenter: Shepard D. Weiner June 25, 2025
Presentation NY Valves 2025 A Contemporary View on Pathophysiology and Clinical Significance of LVOT in HCM Presenter: Anjali Owens June 25, 2025
Presentation NY Valves 2025 SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results Presenter: Pradeep K. Yadav June 25, 2025
Presentation NY Valves 2025 SESAME for the Treatment of Subaortic Membrane: First-in-Human Series Presenter: Yasemin Ciftcikal June 25, 2025
Presentation NY Valves 2025 Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV? Presenter: Hasan Jilaihawi June 25, 2025
Presentation NY Valves 2025 BONAPART: A Novel Mechanical Leaflet Splitting Device Presenter: Eberhard Grube June 25, 2025
Presentation NY Valves 2025 The Evolution of Leaflet Modification Technologies: Emerging Techniques (e.g. UNICORN, BATMAN, etc), Technologies and Future Applications Presenter: Jaffar M. Khan June 25, 2025
Presentation NY Valves 2025 M-TEER for Atrial and Ventricular SMR: Insights from the REPAIR Study Presenter: Philipp von Stein June 25, 2025
Presentation NY Valves 2025 Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System Presenter: Mark J. Ricciardi June 25, 2025
Presentation NY Valves 2025 Effect of TTVR on Preference-Weighted Health Status: A Patient-Centered Sub-Study of the TRISCEND II Pivotal Trial Presenter: Suzanne V. Arnold June 25, 2025